Nectero Medical Announces Initiation of Phase II/III Clinical Trial of the Nectero EAST® System for Treatment of Small- to Medium-Sized Abdominal Aortic Aneurysms
TEMPE, Ariz.--(BUSINESS WIRE)--Jan 18, 2024--
Source: eagletribune.com
Stay updated with breaking news from Aaable Study Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TEMPE, Ariz.--(BUSINESS WIRE)--Jan 18, 2024--
Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease and improve patients' lives, today announced initiation of a Phase II/III clinical trial (stAAAble) to investigate the safety and efficacy...